These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12722126)

  • 21. Report of working party on internal quality control for cervical cytopathology laboratories summary and recommendations.
    Cytopathology; 1996 Feb; 7(1):4-9. PubMed ID: 8833868
    [No Abstract]   [Full Text] [Related]  

  • 22. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
    Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection.
    Davey DD; Cox JT; Austin RM; Birdsong G; Colgan TJ; Howell LP; Husain M; Darragh TM
    J Low Genit Tract Dis; 2008 Apr; 12(2):71-81. PubMed ID: 18369299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cervical smears unsuitable for exclusion of cervical carcinoma].
    Giard RW; Blok P
    Ned Tijdschr Geneeskd; 2000 Jan; 144(2):86-7. PubMed ID: 10674109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Screening of cervical cancer, false negative smears].
    Vassilakos P; de Marval F; Muñoz M
    Rev Med Suisse Romande; 1998 Jan; 118(1):97. PubMed ID: 9580199
    [No Abstract]   [Full Text] [Related]  

  • 26. [New classification in cervical cytology: the Bethesda system].
    Bodó M; Tóth V
    Orv Hetil; 1991 May; 132(19):1039-40. PubMed ID: 2027678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality and liability issues with the Papanicolaou smear: the role of professional organizations in reform initiatives.
    Stanley MW
    Arch Pathol Lab Med; 1997 Mar; 121(3):321-6. PubMed ID: 9111127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bethesda System reporting rates for conventional Papanicolaou tests and liquid-based cytology in a large Chinese, College of American Pathologists-certified independent medical laboratory: analysis of 1394389 Papanicolaou test reports.
    Zheng B; Austin RM; Liang X; Li Z; Chen C; Yan S; Zhao C
    Arch Pathol Lab Med; 2015 Mar; 139(3):373-7. PubMed ID: 25724034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. College of American Pathologists Conference XXX on quality and liability issues with the Papanicolaou smear: introduction.
    Austin RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):227-8. PubMed ID: 9111105
    [No Abstract]   [Full Text] [Related]  

  • 30. New educational methods in cytopathology: a transnational training program in cervical cytology--CYTOTRAIN CD-ROM.
    Chosia M
    Pol J Pathol; 2001; 52(4):219-20. PubMed ID: 11915184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Report disclaimers and informed expectations about Papanicolaou smears: an Australian view.
    Mitchell H
    Arch Pathol Lab Med; 1997 Mar; 121(3):327-30. PubMed ID: 9111128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automation of the Papanicolaou smear: a technology assessment perspective.
    Linder J
    Arch Pathol Lab Med; 1997 Mar; 121(3):282-6. PubMed ID: 9111119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The European aptitude test for cervical cytopathology].
    Branca M
    Pathologica; 2001 Feb; 93(1):28-33. PubMed ID: 11294016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
    Dalla Palma P
    Cytopathology; 1997 Jun; 8(3):210. PubMed ID: 9202897
    [No Abstract]   [Full Text] [Related]  

  • 37. Report of a national workshop on screening for cancer of the cervix.
    Anderson GH
    CMAJ; 1992 Apr; 146(8):1280; author reply 1280, 1284-5. PubMed ID: 1555154
    [No Abstract]   [Full Text] [Related]  

  • 38. Quality assurance in cervical cytopathology.
    Light AM
    Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
    [No Abstract]   [Full Text] [Related]  

  • 39. Quality and liability issues with the Papanicolaou smear: lessons from the science of error prevention.
    Derman H
    Arch Pathol Lab Med; 1997 Mar; 121(3):287-91. PubMed ID: 9111120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pap smear refined.
    Oncology (Williston Park); 1997 Aug; 11(8):1125. PubMed ID: 9268975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.